Incyte announces definitive agreement to acquire Vega Therapeutics

Filed June 8, 2026 · Period ending June 8, 2026 · ~1 min read

Key Changes

• high

  Incyte signed a binding agreement to acquire Vega Therapeutics, Inc., a wholly owned subsidiary of Star Therapeutics, LLC. Financial terms, strategic rationale, and expected closing timeline were not disclosed in the 8-K.

  Item 8.01 verify on EDGAR →
• medium

  The acquisition was announced via press release on June 8, 2026. Full details of the transaction are expected to be in the attached press release (Exhibit 99.1), which was not included in the filing body.

  Exhibit 99.1 verify on EDGAR →